Study finds that attending Historically Black Colleges and Universities (HBCUs) is associated with better cognition in aging ...

Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that the Company’s president and CEO, Lisa Ricciardi intends to ...

The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) found that certain lifestyle interventions improved cognition in older ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the ongoing pursuit by psychology ...

On one side are those who treat AI as a powerful but sometimes faulty service that needs careful human oversight and review ...

Cognition Therapeutics (NASDAQ:CGTX) used its fourth-quarter and full-year 2025 earnings call to outline a shift in development priorities for its lead candidate, zervimesine (CT-1812), with managemen ...

Backed by $200 million in funding, 28-year-old Scott Wu and his team of competitive coders at Cognition are building an AI tool that can program entirely on its own, like an “army of junior engineers.